Global Oral Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 137

Published Date: 08 Jan 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Oral Vaccine Adjuvants market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Vaccine adjuvants (Adjuvant) are a class of substances that can non-specifically change or enhance the body's specific immune response to antigens and play an auxiliary role. Adjuvants can induce the body to produce a long-term and efficient specific immune response, improve the body's protective ability, and at the same time reduce the dosage of immune substances and reduce the production cost of vaccines.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Oral Vaccine Adjuvants industry chain, the market status of Research Application (Veterinary Vaccine Adjuvants, Human Vaccine Adjuvants), Commercial Application (Veterinary Vaccine Adjuvants, Human Vaccine Adjuvants), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oral Vaccine Adjuvants.

Regionally, the report analyzes the Oral Vaccine Adjuvants markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oral Vaccine Adjuvants market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Oral Vaccine Adjuvants market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oral Vaccine Adjuvants industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Veterinary Vaccine Adjuvants, Human Vaccine Adjuvants).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oral Vaccine Adjuvants market.

Regional Analysis: The report involves examining the Oral Vaccine Adjuvants market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oral Vaccine Adjuvants market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Oral Vaccine Adjuvants:
Company Analysis: Report covers individual Oral Vaccine Adjuvants manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oral Vaccine Adjuvants This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Research Application, Commercial Application).

Technology Analysis: Report covers specific technologies relevant to Oral Vaccine Adjuvants. It assesses the current state, advancements, and potential future developments in Oral Vaccine Adjuvants areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oral Vaccine Adjuvants market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Oral Vaccine Adjuvants market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Veterinary Vaccine Adjuvants
Human Vaccine Adjuvants

Market segment by Application
Research Application
Commercial Application

Major players covered
SEPPIC
SDA BIO
Croda International
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Vaccine Adjuvants product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Vaccine Adjuvants, with price, sales, revenue and global market share of Oral Vaccine Adjuvants from 2019 to 2024.
Chapter 3, the Oral Vaccine Adjuvants competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Oral Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Vaccine Adjuvants.
Chapter 14 and 15, to describe Oral Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Oral Vaccine Adjuvants
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Oral Vaccine Adjuvants Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Veterinary Vaccine Adjuvants
        1.3.3 Human Vaccine Adjuvants
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Oral Vaccine Adjuvants Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Research Application
        1.4.3 Commercial Application
    1.5 Global Oral Vaccine Adjuvants Market Size & Forecast
        1.5.1 Global Oral Vaccine Adjuvants Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Oral Vaccine Adjuvants Sales Quantity (2019-2030)
        1.5.3 Global Oral Vaccine Adjuvants Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 SEPPIC
        2.1.1 SEPPIC Details
        2.1.2 SEPPIC Major Business
        2.1.3 SEPPIC Oral Vaccine Adjuvants Product and Services
        2.1.4 SEPPIC Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 SEPPIC Recent Developments/Updates
    2.2 SDA BIO
        2.2.1 SDA BIO Details
        2.2.2 SDA BIO Major Business
        2.2.3 SDA BIO Oral Vaccine Adjuvants Product and Services
        2.2.4 SDA BIO Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 SDA BIO Recent Developments/Updates
    2.3 Croda International
        2.3.1 Croda International Details
        2.3.2 Croda International Major Business
        2.3.3 Croda International Oral Vaccine Adjuvants Product and Services
        2.3.4 Croda International Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Croda International Recent Developments/Updates
    2.4 SPI Pharma
        2.4.1 SPI Pharma Details
        2.4.2 SPI Pharma Major Business
        2.4.3 SPI Pharma Oral Vaccine Adjuvants Product and Services
        2.4.4 SPI Pharma Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 SPI Pharma Recent Developments/Updates
    2.5 Phibro Animal Health Corporation
        2.5.1 Phibro Animal Health Corporation Details
        2.5.2 Phibro Animal Health Corporation Major Business
        2.5.3 Phibro Animal Health Corporation Oral Vaccine Adjuvants Product and Services
        2.5.4 Phibro Animal Health Corporation Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Phibro Animal Health Corporation Recent Developments/Updates
    2.6 Tj Kaiwei
        2.6.1 Tj Kaiwei Details
        2.6.2 Tj Kaiwei Major Business
        2.6.3 Tj Kaiwei Oral Vaccine Adjuvants Product and Services
        2.6.4 Tj Kaiwei Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Tj Kaiwei Recent Developments/Updates
    2.7 Novavax
        2.7.1 Novavax Details
        2.7.2 Novavax Major Business
        2.7.3 Novavax Oral Vaccine Adjuvants Product and Services
        2.7.4 Novavax Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Novavax Recent Developments/Updates
    2.8 Zhuoyue
        2.8.1 Zhuoyue Details
        2.8.2 Zhuoyue Major Business
        2.8.3 Zhuoyue Oral Vaccine Adjuvants Product and Services
        2.8.4 Zhuoyue Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Zhuoyue Recent Developments/Updates
    2.9 Aphios
        2.9.1 Aphios Details
        2.9.2 Aphios Major Business
        2.9.3 Aphios Oral Vaccine Adjuvants Product and Services
        2.9.4 Aphios Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Aphios Recent Developments/Updates
    2.10 GSK
        2.10.1 GSK Details
        2.10.2 GSK Major Business
        2.10.3 GSK Oral Vaccine Adjuvants Product and Services
        2.10.4 GSK Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 GSK Recent Developments/Updates
    2.11 CSL
        2.11.1 CSL Details
        2.11.2 CSL Major Business
        2.11.3 CSL Oral Vaccine Adjuvants Product and Services
        2.11.4 CSL Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 CSL Recent Developments/Updates
    2.12 Brenntag Biosector
        2.12.1 Brenntag Biosector Details
        2.12.2 Brenntag Biosector Major Business
        2.12.3 Brenntag Biosector Oral Vaccine Adjuvants Product and Services
        2.12.4 Brenntag Biosector Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Brenntag Biosector Recent Developments/Updates
    2.13 SEPPIC
        2.13.1 SEPPIC Details
        2.13.2 SEPPIC Major Business
        2.13.3 SEPPIC Oral Vaccine Adjuvants Product and Services
        2.13.4 SEPPIC Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 SEPPIC Recent Developments/Updates
    2.14 SPI Pharma
        2.14.1 SPI Pharma Details
        2.14.2 SPI Pharma Major Business
        2.14.3 SPI Pharma Oral Vaccine Adjuvants Product and Services
        2.14.4 SPI Pharma Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 SPI Pharma Recent Developments/Updates
    2.15 Novavax
        2.15.1 Novavax Details
        2.15.2 Novavax Major Business
        2.15.3 Novavax Oral Vaccine Adjuvants Product and Services
        2.15.4 Novavax Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Novavax Recent Developments/Updates
    2.16 Avanti Polar Lipids
        2.16.1 Avanti Polar Lipids Details
        2.16.2 Avanti Polar Lipids Major Business
        2.16.3 Avanti Polar Lipids Oral Vaccine Adjuvants Product and Services
        2.16.4 Avanti Polar Lipids Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Avanti Polar Lipids Recent Developments/Updates
    2.17 Aphios
        2.17.1 Aphios Details
        2.17.2 Aphios Major Business
        2.17.3 Aphios Oral Vaccine Adjuvants Product and Services
        2.17.4 Aphios Oral Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.17.5 Aphios Recent Developments/Updates

3 Competitive Environment: Oral Vaccine Adjuvants by Manufacturer
    3.1 Global Oral Vaccine Adjuvants Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Oral Vaccine Adjuvants Revenue by Manufacturer (2019-2024)
    3.3 Global Oral Vaccine Adjuvants Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Oral Vaccine Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Oral Vaccine Adjuvants Manufacturer Market Share in 2023
        3.4.2 Top 6 Oral Vaccine Adjuvants Manufacturer Market Share in 2023
    3.5 Oral Vaccine Adjuvants Market: Overall Company Footprint Analysis
        3.5.1 Oral Vaccine Adjuvants Market: Region Footprint
        3.5.2 Oral Vaccine Adjuvants Market: Company Product Type Footprint
        3.5.3 Oral Vaccine Adjuvants Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Oral Vaccine Adjuvants Market Size by Region
        4.1.1 Global Oral Vaccine Adjuvants Sales Quantity by Region (2019-2030)
        4.1.2 Global Oral Vaccine Adjuvants Consumption Value by Region (2019-2030)
        4.1.3 Global Oral Vaccine Adjuvants Average Price by Region (2019-2030)
    4.2 North America Oral Vaccine Adjuvants Consumption Value (2019-2030)
    4.3 Europe Oral Vaccine Adjuvants Consumption Value (2019-2030)
    4.4 Asia-Pacific Oral Vaccine Adjuvants Consumption Value (2019-2030)
    4.5 South America Oral Vaccine Adjuvants Consumption Value (2019-2030)
    4.6 Middle East and Africa Oral Vaccine Adjuvants Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Oral Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    5.2 Global Oral Vaccine Adjuvants Consumption Value by Type (2019-2030)
    5.3 Global Oral Vaccine Adjuvants Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Oral Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    6.2 Global Oral Vaccine Adjuvants Consumption Value by Application (2019-2030)
    6.3 Global Oral Vaccine Adjuvants Average Price by Application (2019-2030)

7 North America
    7.1 North America Oral Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    7.2 North America Oral Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    7.3 North America Oral Vaccine Adjuvants Market Size by Country
        7.3.1 North America Oral Vaccine Adjuvants Sales Quantity by Country (2019-2030)
        7.3.2 North America Oral Vaccine Adjuvants Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Oral Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    8.2 Europe Oral Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    8.3 Europe Oral Vaccine Adjuvants Market Size by Country
        8.3.1 Europe Oral Vaccine Adjuvants Sales Quantity by Country (2019-2030)
        8.3.2 Europe Oral Vaccine Adjuvants Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Oral Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Oral Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Oral Vaccine Adjuvants Market Size by Region
        9.3.1 Asia-Pacific Oral Vaccine Adjuvants Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Oral Vaccine Adjuvants Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Oral Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    10.2 South America Oral Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    10.3 South America Oral Vaccine Adjuvants Market Size by Country
        10.3.1 South America Oral Vaccine Adjuvants Sales Quantity by Country (2019-2030)
        10.3.2 South America Oral Vaccine Adjuvants Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Oral Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Oral Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Oral Vaccine Adjuvants Market Size by Country
        11.3.1 Middle East & Africa Oral Vaccine Adjuvants Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Oral Vaccine Adjuvants Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Oral Vaccine Adjuvants Market Drivers
    12.2 Oral Vaccine Adjuvants Market Restraints
    12.3 Oral Vaccine Adjuvants Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Oral Vaccine Adjuvants and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Oral Vaccine Adjuvants
    13.3 Oral Vaccine Adjuvants Production Process
    13.4 Oral Vaccine Adjuvants Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Oral Vaccine Adjuvants Typical Distributors
    14.3 Oral Vaccine Adjuvants Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oral Vaccine Adjuvants Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Oral Vaccine Adjuvants Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. SEPPIC Basic Information, Manufacturing Base and Competitors
    Table 4. SEPPIC Major Business
    Table 5. SEPPIC Oral Vaccine Adjuvants Product and Services
    Table 6. SEPPIC Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. SEPPIC Recent Developments/Updates
    Table 8. SDA BIO Basic Information, Manufacturing Base and Competitors
    Table 9. SDA BIO Major Business
    Table 10. SDA BIO Oral Vaccine Adjuvants Product and Services
    Table 11. SDA BIO Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. SDA BIO Recent Developments/Updates
    Table 13. Croda International Basic Information, Manufacturing Base and Competitors
    Table 14. Croda International Major Business
    Table 15. Croda International Oral Vaccine Adjuvants Product and Services
    Table 16. Croda International Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Croda International Recent Developments/Updates
    Table 18. SPI Pharma Basic Information, Manufacturing Base and Competitors
    Table 19. SPI Pharma Major Business
    Table 20. SPI Pharma Oral Vaccine Adjuvants Product and Services
    Table 21. SPI Pharma Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. SPI Pharma Recent Developments/Updates
    Table 23. Phibro Animal Health Corporation Basic Information, Manufacturing Base and Competitors
    Table 24. Phibro Animal Health Corporation Major Business
    Table 25. Phibro Animal Health Corporation Oral Vaccine Adjuvants Product and Services
    Table 26. Phibro Animal Health Corporation Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Phibro Animal Health Corporation Recent Developments/Updates
    Table 28. Tj Kaiwei Basic Information, Manufacturing Base and Competitors
    Table 29. Tj Kaiwei Major Business
    Table 30. Tj Kaiwei Oral Vaccine Adjuvants Product and Services
    Table 31. Tj Kaiwei Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Tj Kaiwei Recent Developments/Updates
    Table 33. Novavax Basic Information, Manufacturing Base and Competitors
    Table 34. Novavax Major Business
    Table 35. Novavax Oral Vaccine Adjuvants Product and Services
    Table 36. Novavax Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Novavax Recent Developments/Updates
    Table 38. Zhuoyue Basic Information, Manufacturing Base and Competitors
    Table 39. Zhuoyue Major Business
    Table 40. Zhuoyue Oral Vaccine Adjuvants Product and Services
    Table 41. Zhuoyue Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Zhuoyue Recent Developments/Updates
    Table 43. Aphios Basic Information, Manufacturing Base and Competitors
    Table 44. Aphios Major Business
    Table 45. Aphios Oral Vaccine Adjuvants Product and Services
    Table 46. Aphios Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Aphios Recent Developments/Updates
    Table 48. GSK Basic Information, Manufacturing Base and Competitors
    Table 49. GSK Major Business
    Table 50. GSK Oral Vaccine Adjuvants Product and Services
    Table 51. GSK Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. GSK Recent Developments/Updates
    Table 53. CSL Basic Information, Manufacturing Base and Competitors
    Table 54. CSL Major Business
    Table 55. CSL Oral Vaccine Adjuvants Product and Services
    Table 56. CSL Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. CSL Recent Developments/Updates
    Table 58. Brenntag Biosector Basic Information, Manufacturing Base and Competitors
    Table 59. Brenntag Biosector Major Business
    Table 60. Brenntag Biosector Oral Vaccine Adjuvants Product and Services
    Table 61. Brenntag Biosector Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 62. Brenntag Biosector Recent Developments/Updates
    Table 63. SEPPIC Basic Information, Manufacturing Base and Competitors
    Table 64. SEPPIC Major Business
    Table 65. SEPPIC Oral Vaccine Adjuvants Product and Services
    Table 66. SEPPIC Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 67. SEPPIC Recent Developments/Updates
    Table 68. SPI Pharma Basic Information, Manufacturing Base and Competitors
    Table 69. SPI Pharma Major Business
    Table 70. SPI Pharma Oral Vaccine Adjuvants Product and Services
    Table 71. SPI Pharma Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 72. SPI Pharma Recent Developments/Updates
    Table 73. Novavax Basic Information, Manufacturing Base and Competitors
    Table 74. Novavax Major Business
    Table 75. Novavax Oral Vaccine Adjuvants Product and Services
    Table 76. Novavax Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Novavax Recent Developments/Updates
    Table 78. Avanti Polar Lipids Basic Information, Manufacturing Base and Competitors
    Table 79. Avanti Polar Lipids Major Business
    Table 80. Avanti Polar Lipids Oral Vaccine Adjuvants Product and Services
    Table 81. Avanti Polar Lipids Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 82. Avanti Polar Lipids Recent Developments/Updates
    Table 83. Aphios Basic Information, Manufacturing Base and Competitors
    Table 84. Aphios Major Business
    Table 85. Aphios Oral Vaccine Adjuvants Product and Services
    Table 86. Aphios Oral Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 87. Aphios Recent Developments/Updates
    Table 88. Global Oral Vaccine Adjuvants Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 89. Global Oral Vaccine Adjuvants Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 90. Global Oral Vaccine Adjuvants Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 91. Market Position of Manufacturers in Oral Vaccine Adjuvants, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 92. Head Office and Oral Vaccine Adjuvants Production Site of Key Manufacturer
    Table 93. Oral Vaccine Adjuvants Market: Company Product Type Footprint
    Table 94. Oral Vaccine Adjuvants Market: Company Product Application Footprint
    Table 95. Oral Vaccine Adjuvants New Market Entrants and Barriers to Market Entry
    Table 96. Oral Vaccine Adjuvants Mergers, Acquisition, Agreements, and Collaborations
    Table 97. Global Oral Vaccine Adjuvants Sales Quantity by Region (2019-2024) & (K Units)
    Table 98. Global Oral Vaccine Adjuvants Sales Quantity by Region (2025-2030) & (K Units)
    Table 99. Global Oral Vaccine Adjuvants Consumption Value by Region (2019-2024) & (USD Million)
    Table 100. Global Oral Vaccine Adjuvants Consumption Value by Region (2025-2030) & (USD Million)
    Table 101. Global Oral Vaccine Adjuvants Average Price by Region (2019-2024) & (US$/Unit)
    Table 102. Global Oral Vaccine Adjuvants Average Price by Region (2025-2030) & (US$/Unit)
    Table 103. Global Oral Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
    Table 104. Global Oral Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
    Table 105. Global Oral Vaccine Adjuvants Consumption Value by Type (2019-2024) & (USD Million)
    Table 106. Global Oral Vaccine Adjuvants Consumption Value by Type (2025-2030) & (USD Million)
    Table 107. Global Oral Vaccine Adjuvants Average Price by Type (2019-2024) & (US$/Unit)
    Table 108. Global Oral Vaccine Adjuvants Average Price by Type (2025-2030) & (US$/Unit)
    Table 109. Global Oral Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
    Table 110. Global Oral Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
    Table 111. Global Oral Vaccine Adjuvants Consumption Value by Application (2019-2024) & (USD Million)
    Table 112. Global Oral Vaccine Adjuvants Consumption Value by Application (2025-2030) & (USD Million)
    Table 113. Global Oral Vaccine Adjuvants Average Price by Application (2019-2024) & (US$/Unit)
    Table 114. Global Oral Vaccine Adjuvants Average Price by Application (2025-2030) & (US$/Unit)
    Table 115. North America Oral Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
    Table 116. North America Oral Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
    Table 117. North America Oral Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
    Table 118. North America Oral Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
    Table 119. North America Oral Vaccine Adjuvants Sales Quantity by Country (2019-2024) & (K Units)
    Table 120. North America Oral Vaccine Adjuvants Sales Quantity by Country (2025-2030) & (K Units)
    Table 121. North America Oral Vaccine Adjuvants Consumption Value by Country (2019-2024) & (USD Million)
    Table 122. North America Oral Vaccine Adjuvants Consumption Value by Country (2025-2030) & (USD Million)
    Table 123. Europe Oral Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
    Table 124. Europe Oral Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
    Table 125. Europe Oral Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
    Table 126. Europe Oral Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
    Table 127. Europe Oral Vaccine Adjuvants Sales Quantity by Country (2019-2024) & (K Units)
    Table 128. Europe Oral Vaccine Adjuvants Sales Quantity by Country (2025-2030) & (K Units)
    Table 129. Europe Oral Vaccine Adjuvants Consumption Value by Country (2019-2024) & (USD Million)
    Table 130. Europe Oral Vaccine Adjuvants Consumption Value by Country (2025-2030) & (USD Million)
    Table 131. Asia-Pacific Oral Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
    Table 132. Asia-Pacific Oral Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
    Table 133. Asia-Pacific Oral Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
    Table 134. Asia-Pacific Oral Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
    Table 135. Asia-Pacific Oral Vaccine Adjuvants Sales Quantity by Region (2019-2024) & (K Units)
    Table 136. Asia-Pacific Oral Vaccine Adjuvants Sales Quantity by Region (2025-2030) & (K Units)
    Table 137. Asia-Pacific Oral Vaccine Adjuvants Consumption Value by Region (2019-2024) & (USD Million)
    Table 138. Asia-Pacific Oral Vaccine Adjuvants Consumption Value by Region (2025-2030) & (USD Million)
    Table 139. South America Oral Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
    Table 140. South America Oral Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
    Table 141. South America Oral Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
    Table 142. South America Oral Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
    Table 143. South America Oral Vaccine Adjuvants Sales Quantity by Country (2019-2024) & (K Units)
    Table 144. South America Oral Vaccine Adjuvants Sales Quantity by Country (2025-2030) & (K Units)
    Table 145. South America Oral Vaccine Adjuvants Consumption Value by Country (2019-2024) & (USD Million)
    Table 146. South America Oral Vaccine Adjuvants Consumption Value by Country (2025-2030) & (USD Million)
    Table 147. Middle East & Africa Oral Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
    Table 148. Middle East & Africa Oral Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
    Table 149. Middle East & Africa Oral Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
    Table 150. Middle East & Africa Oral Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
    Table 151. Middle East & Africa Oral Vaccine Adjuvants Sales Quantity by Region (2019-2024) & (K Units)
    Table 152. Middle East & Africa Oral Vaccine Adjuvants Sales Quantity by Region (2025-2030) & (K Units)
    Table 153. Middle East & Africa Oral Vaccine Adjuvants Consumption Value by Region (2019-2024) & (USD Million)
    Table 154. Middle East & Africa Oral Vaccine Adjuvants Consumption Value by Region (2025-2030) & (USD Million)
    Table 155. Oral Vaccine Adjuvants Raw Material
    Table 156. Key Manufacturers of Oral Vaccine Adjuvants Raw Materials
    Table 157. Oral Vaccine Adjuvants Typical Distributors
    Table 158. Oral Vaccine Adjuvants Typical Customers
List of Figures
    Figure 1. Oral Vaccine Adjuvants Picture
    Figure 2. Global Oral Vaccine Adjuvants Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Oral Vaccine Adjuvants Consumption Value Market Share by Type in 2023
    Figure 4. Veterinary Vaccine Adjuvants Examples
    Figure 5. Human Vaccine Adjuvants Examples
    Figure 6. Global Oral Vaccine Adjuvants Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Oral Vaccine Adjuvants Consumption Value Market Share by Application in 2023
    Figure 8. Research Application Examples
    Figure 9. Commercial Application Examples
    Figure 10. Global Oral Vaccine Adjuvants Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Oral Vaccine Adjuvants Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Oral Vaccine Adjuvants Sales Quantity (2019-2030) & (K Units)
    Figure 13. Global Oral Vaccine Adjuvants Average Price (2019-2030) & (US$/Unit)
    Figure 14. Global Oral Vaccine Adjuvants Sales Quantity Market Share by Manufacturer in 2023
    Figure 15. Global Oral Vaccine Adjuvants Consumption Value Market Share by Manufacturer in 2023
    Figure 16. Producer Shipments of Oral Vaccine Adjuvants by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 17. Top 3 Oral Vaccine Adjuvants Manufacturer (Consumption Value) Market Share in 2023
    Figure 18. Top 6 Oral Vaccine Adjuvants Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Global Oral Vaccine Adjuvants Sales Quantity Market Share by Region (2019-2030)
    Figure 20. Global Oral Vaccine Adjuvants Consumption Value Market Share by Region (2019-2030)
    Figure 21. North America Oral Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Oral Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Oral Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Oral Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East & Africa Oral Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Oral Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
    Figure 27. Global Oral Vaccine Adjuvants Consumption Value Market Share by Type (2019-2030)
    Figure 28. Global Oral Vaccine Adjuvants Average Price by Type (2019-2030) & (US$/Unit)
    Figure 29. Global Oral Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
    Figure 30. Global Oral Vaccine Adjuvants Consumption Value Market Share by Application (2019-2030)
    Figure 31. Global Oral Vaccine Adjuvants Average Price by Application (2019-2030) & (US$/Unit)
    Figure 32. North America Oral Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
    Figure 33. North America Oral Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
    Figure 34. North America Oral Vaccine Adjuvants Sales Quantity Market Share by Country (2019-2030)
    Figure 35. North America Oral Vaccine Adjuvants Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 37. Canada Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Mexico Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Europe Oral Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
    Figure 40. Europe Oral Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
    Figure 41. Europe Oral Vaccine Adjuvants Sales Quantity Market Share by Country (2019-2030)
    Figure 42. Europe Oral Vaccine Adjuvants Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. France Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. United Kingdom Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Russia Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Italy Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Oral Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Oral Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Oral Vaccine Adjuvants Sales Quantity Market Share by Region (2019-2030)
    Figure 51. Asia-Pacific Oral Vaccine Adjuvants Consumption Value Market Share by Region (2019-2030)
    Figure 52. China Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Japan Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Korea Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. India Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Southeast Asia Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Australia Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. South America Oral Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
    Figure 59. South America Oral Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
    Figure 60. South America Oral Vaccine Adjuvants Sales Quantity Market Share by Country (2019-2030)
    Figure 61. South America Oral Vaccine Adjuvants Consumption Value Market Share by Country (2019-2030)
    Figure 62. Brazil Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Argentina Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Middle East & Africa Oral Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
    Figure 65. Middle East & Africa Oral Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
    Figure 66. Middle East & Africa Oral Vaccine Adjuvants Sales Quantity Market Share by Region (2019-2030)
    Figure 67. Middle East & Africa Oral Vaccine Adjuvants Consumption Value Market Share by Region (2019-2030)
    Figure 68. Turkey Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Egypt Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Saudi Arabia Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. South Africa Oral Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Oral Vaccine Adjuvants Market Drivers
    Figure 73. Oral Vaccine Adjuvants Market Restraints
    Figure 74. Oral Vaccine Adjuvants Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Oral Vaccine Adjuvants in 2023
    Figure 77. Manufacturing Process Analysis of Oral Vaccine Adjuvants
    Figure 78. Oral Vaccine Adjuvants Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

SEPPIC
SDA BIO
Croda International
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios

Related Reports

Global Oral Vaccine Adjuvants Supply, Demand and Key Producers, 2023-2029

Global Oral Vaccine Adjuvants Supply, Demand and Key Producers, 2023-2029

date 07 Aug 2023

date Medical Devices & Consumables

The global Oral Vaccine Adjuvants market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Oral Vaccine Adjuvants Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Oral Vaccine Adjuvants Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 07 Aug 2023

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Oral Vaccine Adjuvants market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Product Tags

Oral Vaccine Adjuvants

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>